Article Figures & Data
Tables
Pretest DX n Impact on Pretest DX (%) Changed Management Confirmed DX* Changed DX* Expanded DX Carpal tunnel syndrome 34 76.5 0.0 20.6 41.2 Diabetic PN 18 55.6 5.6 16.7 22.2 Other PN 11 36.4 27.3 18.2 27.3 LSR 17 41.2 17.6 5.9 29.4 LSR or PN 20 60.0 35.0 25.0 20.0 Total [n (95% CI)] 100 59 (49–68) 14 (8–22) 18 (12–27) 30 (22–40) * Homogeneity among the pretest diagnostic categories rejected by contingency χ2 test at P < .1.
DX, diagnosis; LSR, lumbosacral radiculopathy; PN, polyneuropathy.
- Table 2.
Changes in Clinical Management Resulting from Computerized Electrodiagnostic Testing (n = 30)
Change Count* Orthopedic referral 9 Metabolic work-up for PN 5 NCS work-up for CTS 4 Prescribe splints 4 Change medication 4 Podiatry referral 3 Order MRI 2 * Sum is >30 because one study had 2 management changes.
PN, polyneuropathy; NCS, nerve conduction studies; CTS, carpal tunnel syndrome; MRI, magnetic resonance imaging.
Reference Studies (n) Diagnosis Before Test (%) Diagnosis After Test (%) CTS LSR/PN Other* Abnormal Confirmed Changed Plan Current study 100 34.0 66.0 0 88.0 59.0 30.0 Kothari et al, 199544 126 26.0 33.0 41.0 60.3 31.7 NA Kothari et al, 199837 100 17.5 27.0 55.6 78.0 49.0 46.0 Lo et al, 200245 348 100 0 0 56.3 48.6 NA Cho et al, 200446 44 0 100 0 81.8 38.6 41.0 * Cervical radiculopathy; brachial and lumbosacral plexopathy; focal neuropathies (radial, ulnar, peroneal, proximal median, tibial); motor neuron disease; myasthenia gravis; and myopathy.
CTS, carpal tunnel syndrome; LSR, lumbosacral radiculopathy; PN, polyneuropathy.